Pfizer Inc., a key player in the biopharmaceutical industry, is well-regarded for its extensive range of medicines and vaccines. With a solid global presence and numerous collaborations, Pfizer remains a notable stock for investors. Price fluctuations and market conditions can influence the stock trajectory.
Pfizer Inc. demonstrates solid fundamentals with a mix of strengths and areas for improvement.
| Category | Score | Score Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 4 | |
| Return On Assets | 4 | |
| Debt To Equity | 1 | |
| Price To Earnings | 2 | |
| Price To Book | 3 |
The historical data provides a comparative view, emphasizing consistency in certain areas.
| Date | Overall | DCF | ROE | ROA |
|---|---|---|---|---|
| 2026-05-28 | 3 | 4 | 4 | 4 |
| Previous | 0 | 4 | 4 | 4 |
The price targets reflect an overall consensus of 'Hold', suggesting moderate volatility.
| High | Low | Median | Consensus |
|---|---|---|---|
| 30 | 25 | 27 | 27 |
Analyst sentiments towards Pfizer Inc. show a prominent 'Hold' recommendation.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 21 | |
| Sell | 2 | |
| Strong Sell | 0 |
Pfizer Inc. holds a strong position in the pharmaceutical industry with a diverse product portfolio. The company's collaboration with several industry leaders enhances its potential for innovation and growth. Although the stock's Debt to Equity ratio suggests potential risks, consistent analyst ratings indicate stable market performance. Investors should consider these factors alongside market trends and financial conditions. The 'Hold' consensus reflects market stability with potential for long-term gains.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.